No pathogenic GNAL mutations in 192 sporadic and familial cases of cervical dystonia


  • The copyright line for this article was changed on October 21, 2014 after original online publication.

  • Study funding: Supported by a Bachman-Strauss Dystonia and Parkinson Foundation grant.

  • Relevant conflicts of interest/financial disclosures: Gavin Charlesworth reports no disclosures. Kailash P. Bhatia has received honoraria/financial support to speak/attend meetings from GSK, Boehringer-Ingelheim, Ipsen, Merz, and Orion pharma companies. He holds grants from the Bachmann-Strauss Dystonia Parkinson foundation, the Dystonia Society UK and the Halley Stewart Trust. Nicholas W. Wood holds grants from the Bachmann-Strauss Dystonia Parkinson foundation, the MRC and the Wellcome Trust.

Recently, using a whole exome sequencing approach, mutations in GNAL were identified as a novel cause of primary dystonia by one group[1] and subsequently confirmed by another.[2] Mutations in this gene appear to cause autosomal dominant, primary dystonia with a cervical predilection and evidence of incomplete penetrance.[1]

The initial discovery paper by Fuchs et al reported GNAL mutations in 6 out of 39 families screened (∼15%). However, in the subsequent study by Vemula et al, only 3 GNAL mutations were detected in 760 subjects with familial or sporadic primary dystonia (<0.5%). An accurate estimate of the prevalence of GNAL mutations is important as a mutation frequency of ∼15% would justify early and widespread genetic testing of GNAL in familial dystonia, whereas a frequency of <0.5% would not.

We screened GNAL by Sanger sequencing using the DNA samples from 192 probands (136 female and 56 male) with either familial or sporadic cervical dystonia, selected from a library of research samples on the basis of a clinical description of focal or segmental dystonia that included the cervical region. Local ethics committee approval was obtained for the study. A family history, defined as one or more first or second-degree relatives with dystonia, was recorded in 84 cases. Tremor was recorded in 53 cases. All familial cases had been screened for TOR1A, THAP1 and ANO3 mutations and were negative.

Primers were designed to amplify all exons, the exon/intron boundaries and the 5′UTRs of both major isoforms of GNAL (ENST00000334049 and ENST00000423027).

We identified only two novel single nucleotide variations in GNAL in three individuals in our case cohort. The first was a missense mutation in exon 2 of the gene (cDNA.1053C>T; P149S in ENST00000334049) that was detected in one individual with onset of cervical dystonia in the 4th decade, with a similarly affected father, suggesting autosomal dominant inheritance. However, segregation analysis revealed the variant had in fact been inherited from his unaffected mother and was also present in his unaffected brother (see Fig. 1A), ruling it out as the cause of the dystonia in this family. The second variant, located in the 5′UTR of isoform 2 (cDNA.199C>T in ENST00000423027), was found in two individuals in our cohort exhibiting onset of cervical dystonia in the 6th decade. One individual was a sporadic case whereas the other was part of family with multiple affected members (see Fig. 1B-C). Despite affecting a highly conserved base (PhyloP score = 4.158), the variant failed to segregate with disease in the family, being absent in two affected individuals (see Fig. 1C).

Figure 1.

Family trees for individuals with novel variants in GNAL.

Genetic pedigrees for individuals with novel variants in GNAL. Affected family members are marked by shaded symbols. The variant found is indicated under the pedigree with transcript ID. Mutational status is indicated by ‘m’ for heterozygous mutation carriers and ‘wt’ for homozygous wildtype alleles. Index cases included in the initial screening are marked with an asterisk.

In summary, we did not identify any mutations in GNAL that could be a cause of the dystonia in 192 cases drawn from the United Kingdom, including 84 familial cases. Our own data suggest that GNAL mutations do not represent a common cause of dystonia — in the U.K. population at least — and that the overall frequency of GNAL mutations may be closer to the figure obtained by Vemula et al[2] than the 15% initially reported by Fuchs et al.[1] This study also emphasises the importance of segregation analysis in establishing the pathogenicity or otherwise of novel variants and suggests that other novel genetic causes of dystonia remain to be identified.

  • Gavin Charlesworth, MRCP,1 Kailash P. Bhatia, FRCP,2 Nicholas W. Wood, FRCP1

  • 1Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK.

  • 2Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, Queen Square, London, UK.

Authors Roles:

Gavin Charlesworth: 1) Research project: Conception, Organisation, Execution; 2) Manuscript: Writing of first draft, redrafting; 3) Acquisition of data; 4) Analysis or interpretation of data

Kailash P. Bhatia: 1) Research project: Conception, Organization, Supervision; 2) Manuscript: Critique; 3) Obtaining funding.

Nicholas W. Wood: 1) Research project: Conception, Organization, Supervision; 2) Manuscript: Critique; 3) Obtaining funding.